Cart
sales@molnova.com
DSPG sodium
CAS No. 200880-42-8
DSPG sodium( —— )
Catalog No. M35916 CAS No. 200880-42-8
1,2-Distearoyl-sn-Glycero-3-Phosphatidylglycerol sodium, catalog number T67435 and CAS number 200880-42-8, is a valuable organic compound for life sciences research.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 10MG | 30 | In Stock |
|
| 25MG | 46 | In Stock |
|
| 50MG | 67 | In Stock |
|
| 100MG | 111 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameDSPG sodium
-
NoteResearch use only, not for human use.
-
Brief Description1,2-Distearoyl-sn-Glycero-3-Phosphatidylglycerol sodium, catalog number T67435 and CAS number 200880-42-8, is a valuable organic compound for life sciences research.
-
Description1,2-Distearoyl-sn-Glycero-3-Phosphatidylglycerol (sodium) is the component of liposomes for drug delivery.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorLiposome
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number200880-42-8
-
Formula Weight801.06
-
Molecular FormulaC42H82NaO10P
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : < 1 mg/mL (insoluble or slightly soluble)
-
SMILES[Na+].CCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC(O)CO)OC(=O)CCCCCCCCCCCCCCCCC
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Momtazi-Borojeni AA, et al. Negatively-charged Liposome Nanoparticles Can Prevent Dyslipidemia and Atherosclerosis Progression in the Rabbit Model. Curr Vasc Pharmacol. 2022;20(1):69-76.?
molnova catalog
related products
-
Pregomisin
Pregomisin shows platelet-activating factor (PAF) antagonistic activity and the IC 50 value is 4.8x10(-5) M.
-
Isostearic acid
Isostearic acid (Isooctadecanoic acid) is an active ingredient in imiquimod formulations that promotes the entry of imiquimod or peripherally secreted cytokines into the brain, and can be used to induce psoriasis-like disease models.
-
(-)-Sparteine
Sparteine is a class 1a antiarrhythmic agent, a sodium channel blocker. The deficient debrisoquine hydroxylation of Sparteine is due to the absence of P-450IID1 protein in the livers of poor metabolizers.
